Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain
NCT00992576
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class
Conditions
Constipation
Interventions
DRUG:
Active Hydromorphone PR + Active Naloxone PR
DRUG:
Active Hydromorphone PR + Placebo Naloxone PR
Sponsor
Mundipharma Research GmbH & Co KG